investigational protease inhibitor, Aptivus (tipranavir)
August 2005
You'll hear about an investigational protease inhibitor, Aptivus (tipranavir).
It's the first NON-peptidic protease inhibitor (PI).
PIs have trouble adapting their shape when HIV protease enzymes mutate. Aptivus is more "flexible"...hopefully making it harder for resistance to develop.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive